Request the price quotation - please

Đã hết hạn nhận báo giá

Find: 16:33 11/09/2025

Bid info

Project name/purchase estimate

League of vaccine - Appointed in 2025 - 2026 of Hai Phong Children's Hospital

Bid name

League of vaccine - Appointed in 2025 - 2026 of Hai Phong Children's Hospital

Basic information of the request for quotation

Request for quotation code

RQ2500012059-00

Status

Posted

Name of request for quotation

Request the price quotation - please

Unit requesting quote

Haiphong children's hospital

Address of the unit requesting a quote

City Hải Phòng

Address of the unit requesting a quote (After merge)

Viet Duc Street, Phường Kiến An, City Hải Phòng

Categorize quotation requests

Bidding package for purchasing medicine

Contact information of the person responsible for receiving the quotation

Full Name

Nguyễn Thị Kim Thanh

Position

In charge of the Faculty of Pharmacy

Phone number

0914450483

Address

Faculty of Pharmacy - Hai Phong Children's Hospital. Address: Viet Duc Street, Kien An Ward, Hai Phong City

[email protected]

How to receive quotation

Form of receiving quotation

Offline Email

Location of request for quotation

http://muasamcong.mpi.gov.vn

Quotation acceptance time

Since 11/09/2025 16:32 To date 23/09/2025 16:30

Validity period of quotation

120 Day kể từ ngày 23/09/2025 16:30

Request for quotation

Content of request for quotation

Filter data

Show: data/page

No	Medicine code	Active ingredient name	Technical criteria group	Concentration or content	How to use	Dosage form	Unit	Quantity
1	Ge01	Rota virus, reducing toxicity type G1P [8]	4	≥ 2 million pfu/2ml	Drink	Oral solution	Jar	140
2	GE02	Each 1 dose of vaccines - please reconstitue (0.5 ml) contains: Inactive rabies virus (Wistar PM/Wi 30 1503-3M) ≥ 2.5 IU	1	Each 1 dose of vaccines - please reconstitue (0.5 ml) contains: Inactive rabies virus (Wistar PM/Wi 30 1503-3M) ≥ 2.5 IU	Inject	East dried powder vaccine and reconstituted solvent	Jar	1.500
3	GE03	Measles virus live, reduce poison, Aik-C strain	4	≥ 1000 pfu/dose 0.5 ml	Inject	Dough Dry phase injection	Dose	3.700
4	GE04	A/Victoria/4897/2022 (H1N1) PDM09 - Using equivalent strains (A/Victoria/4897/2022, IVR -238); A/Darwin/9/2021 (H3N2) - Using equivalent strains (a/darkwin/9/2021, IVR -228); B/Austria/1359417/2021 - Use the same strain (B/Michigan/01/2021, Wild strain); B/phuket/3073/2013 - Use strains equivalent (B/phuket/3073/2013, strain feral)	1	Each dose of 0.5ml of vaccine (thin, inactive) contains: a/Victoria/4897/2022 (H1N1) PDM09 - Using the same strain (A/Victoria/4897/2022, IVR -238) 15 mcg HA; A/Darwin/9/2021 (H3N2) - Use equivalent strains (a/darkwin/9/2021, IVR -228) 15 mcg HA; B/Austria/1359417/2021 - Use equivalent strains (b/michigan/01/2021, wild strain) 15 mcg ha; B/phuket/3073/2013 - Use the same strain (b/phuket/3073/2013, wild strain) 15 mcg ha	Inject	Injection	Syringe	280
5	GE05	Each dose of 0.5ml contains 30mcg protein L1 HPV type 6; 40mcg protein L1 HPV type 11; 60mcg protein L1 HPV type 16; 40mcg protein l1 hpv type 18; 20mcg protein L1 HPV for each type 31,33,45,52 and 58	1	Each dose of 0.5ml contains 30mcg protein L1 HPV type 6; 40mcg protein L1 HPV type 11; 60mcg protein L1 HPV type 16; 40mcg protein l1 hpv type 18; 20mcg protein L1 HPV for each type 31,33,45,52 and 58	Inject	Injection	Syringe	1.450
6	GE06	HBsAg surface protein (purity ≥ 95%)	5	10mcg/0.5ml	Inject	Injection	Jar	3.100
7	GE07	HBsAg surface protein (purity ≥ 95%)	5	20mcg/1ml	Inject	Injection	Jar	2.300
8	GE08	Each dose of 0.5 ml of reverting vaccine contains: Japanese encephalitis virus SA14-14-2 recombinant, living, reducing poison	5	4.0 - 5.8 log pfu	Inject	Dried powder	Jar	720
9	GE09	Type 1 polysaccharid pneumococcal polysaccharid; Serum 3 polysaccharide pneumococcal bacteria; Type 4 polysaccharide pneumococcal; Type 5 polysaccharide pneumococcal; Type 6A polysaccharide pneumococcal; Type 6b polysaccharide pneumococcal; Type 7f polysaccharide pneumococcal; Type 9V polysaccharide pneumococcal; Type 14 polysaccharide pneumococcal; Type 18C polysaccharide pneumococcal; Type 19A polysaccharide pneumococcal; Type 19f polysaccharide pneumococcal; Tip serum 23F polysaccharide pneumococcal bacteria (plus CRM197 transport protein)	1	Type 1 polysaccharid pneumococcal polysaccharid 2.2mcg; Type 3 polysaccharide pneumococcal bacteria 2.2mcg; Type 4 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 5 polysaccharide pneumococcal bacteria 2.2mcg; Type 6A polysaccharide pneumococcal bacteria 2.2mcg; Type 6b polysaccharid pneumococcal pneumococcal pneumococcal pneumococcal. Type 7f polysaccharide pneumococcal bacteria 2.2mcg; Type 9V polysaccharide pneumococcal bacteria 2.2mcg; Type 14 polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 18C polysaccharide pneumococcal pneumococcal bacteria 2.2mcg; Type 19A polysaccharid pneumococcal pneumococcal bacteria 2.2mcg; Type 19f polysaccharide pneumococcal bacteria 2.2mcg; Type 23f polysaccharide pneumococcal pneumococcal 2.2mcg (plus CRM197 32mcg shipping protein)	Inject	Injection	Syringe	1.800
10	GE10	OKA/Merck Varicella Virus, Live, ATTNAIDED> = 1350 PFU/Vial	1	> = 1350pfu/vial	Inject	East dried powder with solvent jar	Jar	600
11	GE11	Membrane meningococcal protein group B - 50mcg; Polysaccharide cerebral cerebral cerebral tissue group C: 50mcg	5	Membrane meningococcal protein group B - 50mcg; Polysaccharide cerebral cerebral cerebral tissue group C: 50mcg/ 0.5ml	Inject	Injection	Jar	870
12	GE12	Vials (0.5ml): Measles virus> = 1,000 TCID50; Mumps virus> = 12,500 ccID50; Rubella virus> = 1,000 ccID50	1	Vials (0.5ml): Measles virus> = 1,000 TCID50; Mumps virus> = 12,500 ccID50; Rubella virus> = 1,000 ccID50	Inject	East dried powder injected	Jar	900
13	GE13	Each dose (0.5 ml) contains: - Synthetic protein (fusion protein) NHBA NHBA NHBA Neisseria Meningitidis Group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. - Synthetic protein FHBP Neisseria Meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg	1	Each dose (0.5 ml) contains: - Synthetic protein (fusion protein) NHBA NHBA NHBA Neisseria Meningitidis Group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. - Synthetic protein FHBP Neisseria Meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg	Inject	Injection	Box	300
14	GE14	Inactive antigen in influenza A virus (H1N1); Pure antigen inactivating influenza A virus (H3N2); Pure antigen inactivating influenza virus B; Pure antigen inactivation of influenza virus B	2	15 mcg; 15 mcg; 15 mcg; 15 mcg	Inject	Injection	Dose	1.500
15	GE15	1 dose (0.5 ml): Mocca polysaccharide (serum group A) (unit price plus) 4 µg (mcg); Moco brain polysaccharide (serum C) (unit price plus) 4 µg (MCG); Mocca polysaccharide (serum medical group) (unit price plus) 4 µg (mcg); Mocca polysaccharide (Serum group W-135) (Collective unit price) 4 µg (MCG); - Diphtheria detoxification protein (polysaccharide plus protein for all serum groups)* (* The amount of diphtheria detox is the estimated amount and depends on the ratio between polysaccharide plus and protein) 48 µg (MCG)	5	1 dose (0.5 ml): Mocca polysaccharide (serum group A) (unit price plus) 4 µg (mcg); Moco brain polysaccharide (serum C) (unit price plus) 4 µg (MCG); Mocca polysaccharide (serum medical group) (unit price plus) 4 µg (mcg); Mocca polysaccharide (Serum group W-135) (Collective unit price) 4 µg (MCG); - Diphtheria detoxification protein (polysaccharide plus protein for all serum groups)* (* The amount of diphtheria detox is the estimated amount and depends on the ratio between polysaccharide plus and protein) 48 µg (MCG)	Inject	Injection solution	Jar	600
16	GE16	Each dose of 0.5ml reconstituted vaccine contains: Raw measles virus, reducing poison (Schwarz strain) ≥ 10^3.0 ccID50; Virus of mumps, reduced poison (Rit 4385) ≥ 10^3.7 ccID50; Rubella virus live, reducing poison (Wistar strain to 27/3) ≥ 10^3.0 ccID50	1	Each dose of 0.5ml reconstituted vaccine contains: Raw measles virus, reducing poison (Schwarz strain) ≥ 10^3.0 ccID50; Virus of mumps, reduced poison (Rit 4385) ≥ 10^3.7 ccID50; Rubella virus live, reducing poison (Wistar strain to 27/3) ≥ 10^3.0 ccID50	Inject	East dried vaccine powder	Box	300
17	GE17	Japanese encephalitis virus, pure (SA 14-14-2)	5	6mcg/0.5ml	Inject	Injection	Jar	400
18	GE18	Each dose of 0.5ml contains: polysaccharide brain meningococcal (serum a) (unit price plus)* 10mcg; Mocca brain polysaccharide (serum C) (unit price plus)10mcg; Mocca polysaccharide (Serum group W135) (Collective unit price) 10mcg; Polysaccharide brain meningococcal (serum medical group) (unit price plus) * 10mcg * is added to the carrier is a tetanus detoxification protein about 55mcg	5	Each dose of 0.5ml contains: polysaccharide brain meningococcal (serum a) (unit price plus)* 10mcg; Mocca brain polysaccharide (serum C) (unit price plus)10mcg; Mocca polysaccharide (Serum group W135) (Collective unit price) 10mcg; Polysaccharide brain meningococcal (serum medical group) (unit price plus) * 10mcg * is added to the carrier is a tetanus detoxification protein about 55mcg	Inject	Injection solution	Box	300
19	Ge19	Pure hepatitis B virus surface ≈ 20µg/1ml	4	Pure hepatitis B virus surface ≈ 20µg/1ml	Inject	Injection	Jar	1.200
20	GE20	Pure hepatitis B virus surface ≈ 10µg/0.5ml	4	Pure hepatitis B virus surface ≈ 10µg/0.5ml	Inject	Injection	Jar	2.000

Approval decision information

Approval date

11/09/2025

Approval decision code

200/BVNHP-KD

Approval decision file

Downloading files directly on the new Public Procurement System requires a computer using Windows operating system and installing Client Agent software (Linux and MacOS operating systems cannot install Client software yet). Therefore, to be able to download files on smartphones, tablets or computers using operating systems other than Windows, you need to use DauThau.info software to download files.
To download, please Login or Register

200.BVNHP-KD.pdf

Files with this icon are not supported by the public procurement system for direct download in normal mode. Visit DauThau.info and select Quick Download mode to download the file if you do not use Windows with Agent. DauThau.info supports downloading on most modern browsers and devices!
In case it is discovered that the BMT does not fully attach the E-HSMT file and design documents, the contractor is requested to immediately notify the Investor or the Authorized Person at the address specified in Chapter II-Data Table in E- Application form and report to the Procurement News hotline: 02437.686.611

Utilities for you

Follow quote requests

The Track Request for Quotation function helps you quickly and promptly receive email notifications of changes to Request for Quotation "Request the price quotation - please". Our software will track the requests for quotations that you have registered for you. When there is any change, it will immediately send you an email notification.

Receive similar quote requests via email

To be one of the first to receive similar Requests for Quotations by email: "Request the price quotation - please" as soon as they are published, subscribe to DauThau.info's VIP 8 package.

You did not use the site, Click here to remain logged. Timeout: 60 second